Characteristic | Overall cohort (n = 588) | Living donor recipients (n = 500) | Deceased donor recipients (n = 87) | P-value* |
---|---|---|---|---|
Clinical outcomes: | ||||
Readmission rate within 30 days (%) | 88.9% | 88.4% | 92.0% | 0.430 |
Mean hospital length of stay (days) | 4.0 ± 4.1 | 3.9 ± 4.0 | 4.6 ± 4.6 | 0.259 |
Graft rejection episodes | 110 (18.7%) | 69 (13.8%) | 41 (47.1%) | 0.000 |
Model Performance Metrics: | ||||
AUC (95% CI) | 0.837 (0.802–0.872) | 0.787 (0.738–0.836) | 0.762 (0.685–0.839) | N/A |
Sensitivity | 0.388 | 0.402 | 0.412 | N/A |
Specificity | 0.72 | 0.69 | 0.71 | N/A |
Accuracy | 0.796 ± 0.050 | 0.778 ± 0.061 | 0.783 ± 0.058 | N/A |
Precision | 0.629 ± 0.090 | 0.654 ± 0.082 | 0.643 ± 0.097 | N/A |
F1-Score | 0.469 ± 0.105 | 0.453 ± 0.101 | 0.498 ± 0.112 | N/A |
Feature Importance (SHAP Contribution %): | ||||
Length of hospital stay | 20.6% | 24.5% | 20.1% | N/A |
Post-transplant systolic BP | 17.2% | 21.2% | 16.7% | N/A |
Pre-transplant BMI | 9.8% | 2.6% | 12.6% | N/A |
Pre-transplant diastolic BP | 3.7% | 1.5% | 2.9% | N/A |
Post-transplant BMI | 3.2% | 5.4% | 3.3% | N/A |
Pre-transplant HbA1c | 1.5% | 9.9% | 3.5% | N/A |
Post-transplant eGFR | 2.6% | 8.8% | 2.6% | N/A |